A High-Density Tissue Microarray From Patients With Clinically Localized Prostate Cancer Reveals ERG and TATI Exclusivity in Tumor Cells

Prostate Cancer and Prostatic Diseases - United Kingdom
doi 10.1038/pcan.2013.7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Detection and Phenotyping of Circulating Tumor Cells in High-Risk Localized Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2015English

Radiation Therapy for Clinically Localized Prostate Cancer

JAMA - Journal of the American Medical Association
Medicine
1999English

TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer Progression

Journal of Cancer Science & Therapy
2012English

TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

European Urology
Urology
2011English

Systematic Analysis Reveals Molecular Characteristics of ERG-negative Prostate Cancer

Scientific Reports
Multidisciplinary
2018English

Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer

Clinical Governance: An International Journal
2009English

Biopsy Tissue Microarray Study of Ki-67 Expression in Untreated, Localized Prostate Cancer Managed by Active Surveillance

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2008English

Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients From India

Journal of Cancer
Oncology
2013English

20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer

JAMA - Journal of the American Medical Association
Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy